Katona I., B .Sperlagh, A. Sik, A. Kafalvi, E.S.
Vizi, K. Mackie, T.F. Freund. Presynaptically
located CB1 cannabinoid receptors regulate
GABA release from axon terminals of specific
hippocampal interneurons. J. Neurosci., 19, 1999,
No11, 4544-4558.
Tsou K., K. Mackie, M.C. Sanudo-Pena, J.M.
Walker. Cannabinoid CB1 receptors are localized
primarily on cholecystokinin-containing
GABAergic interneurons in the rat hippocampal
formation. Neurosci., 93, 1999, No 3, 969-975.
Rodriguez J.J., K. Mackie, V.M. Pickel.
Ultrastructural localization of the CB1
cannabinoidreceptor in μ-opioid receptor patches
of the rat caudate putamen nucleus. J. Neurosci.,
, 2001, No 3, 823-833.
Bandler R., K. A. Keay, N. Floyd, J. Price. Central
circuits mediating patterned autonomic activity
during active vs. passive emotional coping. Brain
Research Bulletin, 53, 2000, No 1, 95-104.
Wilson R. I., R. A. Nicoll. Endogenous
cannabinoids mediate retrograde signalling at
hippocampal synapses. Nature, 410, 2001, No
, 588-592.
Basbaum A.I., H.L. Fields. Annu. Rev. Neurosci., 7,
, 309-338.
Xing Xing J., J. J. Li. Endogenous pain control
systems: brainstem spinal pathways and
endorphin circuitry. Neurophysiol., 97, 2007,
-511.
Butler R.K., D.P. Finn. Stress- induced analgesia.
Prog. Neurobiol., 88, 2009, No 3, 184-202.
Bocheva A, E. Dzambazova-Maximova.
Antiopioid properties of the TYR-MIF-1 family.
Methods Find Exp. Clin. Pharmacol., 26, 2004, No
, 673- 677.
Bocheva A, E. Dzambazova-Maximova. Effects of
Tyr-MIF`s family of peptides on immobilization
stress-induced antinociception in rats. Folia Med
(Plovdiv), 46, 2004, No 2, 42- 46.
Bocheva, A., E. Dzambazova-Maximova, N.
Lambadjieva. Interaction between peptides of
Tyr-MIF-1 family, morphine and nitric oxide in
nociception. Compt. Rend. Bulg. Acad. Sci., 57,
, No 3, 97-102.
Von Bohlen und Halbach O., R. Dermietzel.
In: Neurotransmitters and neu- romodulators:
Handbook of receptors and biological Efects (2nd
Ed.), Weinheim, Wiley-VCH Verlag GmbH & Co.
KgaA, 2006, 347-349.
13. Hohmann A.G., R.L. Suplita, N.M. Bolton,
M.H. Neely, D. Fegley, R. Mangieri, J.F. Krey, J.M.
Walker, P.V. Holmes, J.D. Crystal, A. Duranti,
A. Tontini, M. Mor, G. Tarzia, Piomelli D. An
endocannabinoid mechanism for stressinduced
analgesia. Nature, 435, 2005, No 7045, 1108- 1112.
Tsou K., S. Brown, M.C. Sanudo-Pena, K. Mackie,
J.M. Walker. Immunohistochemical distribution
of cannabinoid CB1 receptors in the rat central
nervous system. Neurosci., 83, 1998, No 2,
-411.
Abrams D.I., P.Couey, S.B. Shade, M.E. Kelly, N.L.
Benowitz. Cannabinoid-opioid interaction in
chronic pain. Clin. Pharmacol. Ther. 90, 2011, No
, 844- 851.
Fattore L., D. Vigano, P. Fadda, T. Rubino, W.
Fratta, D. Parolaro. Bidirectional regulation of
mu-opioid and CB1-cannabinoid receptor in rats
self-administering heroin or WIN 55,212-2. Eur J
Neurosci., 25, 2007, No 7, 2191- 2200.
Smith P.A., D.E. Selley, L.J. Sim-Selley, S.P.
Welch. Low dose combination of morphine
and delta9-tetrahydrocannabinol circumvents
antinociceptive tolerance and apparent
desensitization of receptors. Eur. J. Pharmacol.,
, 2007, No 2-3, 129- 137.
Wilson A., L. Maher, M. Morgan. Repeated
cannabinoid injections into the rat periaqueductal
gray enhance subsequent morphine
antinociception. Neuropharmacol. 55, 2008, No 7,
- 1225.
Wilson R.I., R.A. Nicoll. Endocannabinoid
signaling in the brain. Science, 296, 2002, No
, 678-682.
Alger B.E. Retrograde signaling in the
regulation of synaptic transmission: focus on
endocannabinoids. Prog Neurobiol, 68, 2002, No
, 247- 286.